Physician profile
Anna M Pearson
NPI 1982077418
$2,228.46
in general payments reported to CMS, 2019-2025
24 companies · $94.14 in 2025
The $94.14 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $843 · 2022: $256 · 2023: $751 · 2024: $284 · 2025: $94.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $667.69 | 2021-2025 | Airsupra, Farxiga |
| Edwards Lifesciences Corporation | $157.33 | 2023 | Hemosphere |
| Abiomed | $145.36 | 2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.22 | 2021 | |
| Merz North America, INC. | $135.34 | 2022 | |
| Janssen Pharmaceuticals, INC | $122.42 | 2021 | |
| Esperion Therapeutics, INC. | $114.98 | 2021 | |
| Neurocrine Biosciences, INC. | $114.48 | 2023 | Ingrezza |
| Regeneron Healthcare Solutions, INC. | $109.65 | 2023 | Libtayo |
| Scpharmaceuticals INC. | $106.00 | 2024 | |
| Lilly USA, LLC | $79.50 | 2022 | |
| Inspire Medical Systems, INC. | $69.25 | 2023-2024 | Inspire |
| Mallinckrodt Hospital Products INC. | $39.28 | 2023 | Acthar |
| Jazz Pharmaceuticals INC. | $32.71 | 2021 | |
| United Therapeutics Corporation | $30.50 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vapotherm INC | $27.47 | 2022 | |
| Itamar Medical INC | $20.55 | 2023 | Watchpatone |
| 3b Medical, INC. | $18.97 | 2024 | Luna |
| Actelion Pharmaceuticals US, INC. | $17.57 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.46 | 2023 | Nuzyra |
| Genzyme Corporation | $16.59 | 2021 | |
| Sunovion Pharmaceuticals INC. | $16.09 | 2021 | |
| Abbvie INC. | $13.79 | 2022 | |
| Glaxosmithkline, LLC. | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.